← Back to catalogue

PeriWatch® Cues™

FDA UDI

Class II (US FDA UDI)

by Perigen Solutions Ltd

Identity

Trade Name
PeriWatch® Cues™ FDA UDI
Generic Name
Obstetrical monitoring/analysis software FDA UDI
Device Name
PeriWatch® Cues™ is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at ≥36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations. FDA UDI
Model / Reference
02.10.xx FDA UDI
Description
PeriWatch® Cues™ is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at ≥36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations. FDA UDI

Identifiers

Primary DI / UDI-DI
B087PWCUES02101 FDA UDI
FDA Product Code
HGM FDA UDI
GMDN Term
Obstetrical monitoring/analysis software FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
884.2740 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Obstetrical monitoring/analysis software

PeriWatch® Cues™ by Perigen Solutions Ltd — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Obstetrical monitoring/analysis software.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 26de1f07-7008-49e7-b2b1-908fffafe450 34 fields · synced May 29, 2026